feed,title,long_url,short_url
GN:T:DL,Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF - PR Newswire,https://news.google.com/rss/articles/CBMinwJBVV95cUxPRFdycnJIUFMwYWZXenJYUkstQnkxc1h4Tm9sc241bWFtRFBOd3dTUlpTMDdIUjY2NWszSVFkVmJsWlAzbGtBbXZKUmdZdndJTjhOd2Y2VDdhZjJuRmNBYnRnb3RSSGt0bTMyWGRhVFM3dFM4S1lGZW95cXBycVlqakNKX2lfY1dYWEZwcUJmNmh4V2JjbGlpbUo0eWptZmstblMwTGJzM3oxbjZfZFl5Smx0Si04UVl4aGtldDNSdnoydW5YdlN0eWNuTnVVRmV4Y0tmd1p2RExTX2Zwd0Z6UGlqZVdYMjFqLUVjUUc5dU0tNlB6aEFHaEVwcTh3c1Z3UlhteTN6ZGZxdF9majFNRl9WbVphdGlhaTk5cWZ6Yw?oc=5,https://da.gd/7KLaC
